Dr. Fonarow's research Interests center on acute and chronic heart failure, preventative cardiology, quality of care, outcomes and implementing treatment systems to improve clinical outcomes. Dr. Fonarow has published over 900 research studies and clinical trials in heart failure, disease management, preventative cardiology, and outcomes research. He has also developed and successfully implemented a comprehensive atherosclerosis treatment program at the UCLA Medical Center (Cardiovascular Hospitalization Atherosclerosis Management Program: CHAMP), which served as the model for the American Heart Association's Get with The Guidelines Program. Dr. Fonarow received the outstanding UCLA Cardiology Faculty Teaching Award in 1997 and was honored by the American College of Cardiology with the W. Proctor Harvey Young Teacher Award in 1998. He received an AHA Award of Meritorious Achievement in 2004. In 2009, he received the Raymond D. Bahr Award of Excellence and the Turning Guidelines into lifelines Award from the AHA. In 2014, 2015, and 2016, Thomson Reuters selected Dr. Fonarow for the list of Highly Cited Researchers, which identifies the world's most influential contemporary researchers across 21 scientific fields with the greatest number of published articles that received marks for exceptional impact. In 2015, Dr. Fonarow received a Clinical Research Forum Distinguished Clinical Achievement Award.
Eliot Corday Professor of Cardiovascular Medicine and Science, Director, Ahmanson-UCLA Cardiomyopathy Center, Co-Chief, UCLA Division of Cardiology, Co-Director, UCLA Preventive Cardiology Program, David Geffen School of Medicine at UCLA, Los Angeles, California